{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:52:49Z","timestamp":1772769169059,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Introduction and hypothesis<\/jats:title>\n                <jats:p>To determine the effectiveness of a prescription digital therapeutic (pDTx) in reducing urinary incontinence (UI) symptoms in real-world users.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective cohort study of real-world data from users of a pDTx designed to guide pelvic floor muscle training(PFMT) between July 1, 2020\u2013December 31, 2021. The primary outcome was UI symptom change as reported via in-app Urogenital Distress Inventory (UDI-6). Included subjects were female,\u2009\u2265\u200918\u00a0years with a diagnosis of stress, urgency, or mixed UI who completed the UDI-6 at baseline and 8 weeks. Demographic, symptom, and adherence data were summarized. Paired <jats:italic>t<\/jats:italic>-test and Wilcoxon signed rank test were used to analyze change in outcomes from baseline to 8 weeks across adherence and UI diagnosis groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 532 women with UI, 265 (50%) met criteria and were included in the analysis. Mean age was 51.2\u2009\u00b1\u200911.5\u00a0years (range 22\u201384, <jats:italic>N<\/jats:italic>\u2009=\u2009265). Mean body mass index (BMI) was 27.3\u2009\u00b1\u20096.2\u00a0kg\/m<jats:sup>2<\/jats:sup> (range 15.2\u201346.9, <jats:italic>N<\/jats:italic>\u2009=\u2009147). Most participants had stress UI (59%) followed by mixed UI (22%), urgency UI\/OAB (11%), and unspecified UI (8%). UDI-6 scores improved by 13.90\u2009\u00b1\u200915.53 (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001); 62% met or exceeded MCID. Device-reported PFMT adherence was 72% at 4 weeks and 66% at 8 weeks (100%\u2009=\u200914 uses\/week). Participants in each diagnosis category reported significant improvement on UDI-6 score from baseline to 8 weeks. No association between UDI-6 score improvement and adherence category, age, BMI, or UI subtype was identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrates effectiveness of a pDTx in reducing UI symptoms in a real-world setting. Users achieved statistically and clinically significant symptom improvement over an 8-week period.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00192-022-05321-3","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T10:02:59Z","timestamp":1660557779000},"page":"1083-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A digital health program for treatment of urinary incontinence: retrospective review of real-world user data"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4168-9575","authenticated-orcid":false,"given":"Laura E.","family":"Keyser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha J.","family":"Pulliam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena M.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"5321_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000001127","author":"UJ Patel","year":"2022","unstructured":"Patel UJ, Godecker AL, Giles DL, Brown HW. Updated prevalence of urinary incontinence in women: 2015\u20132018 national population-based survey data. Female Pelvic Med Reconstr Surg. 2022. https:\/\/doi.org\/10.1097\/SPV.0000000000001127.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"5321_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00192-009-0976-9","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, De Ridder D, Freeman RM, et al. An international urogynecological association \/ international continence society joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4\u201320. https:\/\/doi.org\/10.1007\/s00192-009-0976-9.","journal-title":"Neurourol Urodyn"},{"key":"5321_CR3","unstructured":"ACOG Practice Bulletin. Urinary incontinence in women. 2018. https:\/\/www.acog.org\/-\/media\/Practice-Bulletins\/Committee-on-Practice-Bulletins----Gynecology\/pb155.pdf?dmc=1&ts=20180423T2314120185."},{"key":"5321_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/nau","volume":"34","author":"J Hay-Smith","year":"2015","unstructured":"Hay-Smith J, Dean S, Burgio KL, et al. Pelvic floor muscle training adherence \u201cmodifiers\u201d: a review of primary qualitative studies - 2011 ICS state-of-the-science seminar research paper III of IV. Neurourol Urodyn. 2015;34:622\u201331. https:\/\/doi.org\/10.1002\/nau.","journal-title":"Neurourol Urodyn"},{"key":"5321_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00192-009-0853-6","volume":"20","author":"MD Moen","year":"2009","unstructured":"Moen MD, Noone MB, Vassallo BJ, Elser DM. Pelvic floor muscle function in women presenting with pelvic floor disorders. Int Urogynecol J. 2009;20:843\u20136. https:\/\/doi.org\/10.1007\/s00192-009-0853-6.","journal-title":"Int Urogynecol J"},{"key":"5321_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11934-015-0572-0","volume":"17","author":"E Lamin","year":"2016","unstructured":"Lamin E, Parrillo LM, Newman DK, Smith AL. Pelvic floor muscle training: underutilization in the USA. Curr Urol Rep. 2016;17:1\u20137. https:\/\/doi.org\/10.1007\/s11934-015-0572-0.","journal-title":"Curr Urol Rep"},{"key":"5321_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/nau.24256","volume":"39","author":"VE Salmon","year":"2020","unstructured":"Salmon VE, Hay-Smith EJC, Jarvie R, et al. Implementing pelvic floor muscle training in women\u2019s childbearing years: A critical interpretive synthesis of individual, professional, and service issues. Neurourol Urodyn. 2020;39:863\u201370. https:\/\/doi.org\/10.1002\/nau.24256.","journal-title":"Neurourol Urodyn"},{"key":"5321_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/JU.0000000000000223","volume":"202","author":"E Erekson","year":"2019","unstructured":"Erekson E, Hagan KA, Austin A, et al. Outpatient evaluation and management visits for urinary incontinence in older women. J Urol. 2019;202:333\u20138. https:\/\/doi.org\/10.1097\/JU.0000000000000223.","journal-title":"J Urol"},{"key":"5321_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00192-019-04012-w","volume":"31","author":"S Bernard","year":"2020","unstructured":"Bernard S, Boucher S, McLean L, Moffet H. Mobile technologies for the conservative self-management of urinary incontinence: a systematic scoping review. Int Urogynecol J. 2020;31:1163\u201374. https:\/\/doi.org\/10.1007\/s00192-019-04012-w.","journal-title":"Int Urogynecol J"},{"key":"5321_CR10","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00192-020-04340-2","volume":"31","author":"Z Huang","year":"2020","unstructured":"Huang Z, Wu S, Yu T, Hu A. Efficacy of telemedicine for urinary incontinence in women: a systematic review and meta-analysis of randomized controlled trials. Int Urogynecol J. 2020;31:1507\u201313. https:\/\/doi.org\/10.1007\/s00192-020-04340-2.","journal-title":"Int Urogynecol J"},{"key":"5321_CR11","doi-asserted-by":"publisher","unstructured":"Risame Ueda da Mata K, Cristina Monica Costa R, dos Santos Monteiro Carbone \u00c9, et al. Telehealth in the rehabilitation of female pelvic floor dysfunction: a systematic literature review. Int Urogynecol J. 2020;32:249\u201359.\u00a0https:\/\/doi.org\/10.1007\/s00192-020-04588-8.","DOI":"10.1007\/s00192-020-04588-8"},{"key":"5321_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00192-020-04542-8","volume":"32","author":"CHJ Ferreira","year":"2021","unstructured":"Ferreira CHJ, Driusso P, Haddad JM, et al. A guide to physiotherapy in urogynecology for patient care during the COVID-19 pandemic. Int Urogynecol J. 2021;32:203\u201310. https:\/\/doi.org\/10.1007\/s00192-020-04542-8.","journal-title":"Int Urogynecol J"},{"key":"5321_CR13","unstructured":"Women\u2019s Preventive Service Initiative, The American College of Obstetricians and Gynecologists. FAQ for Telehealth Services. In: Women\u2019s Prev. Serv. Initiat. website. 2020. https:\/\/www.womenspreventivehealth.org\/wp-content\/uploads\/WPSI-Telehealth-FAQ.pdf. Accessed 19 Apr 2021."},{"key":"5321_CR14","doi-asserted-by":"publisher","unstructured":"Weinstein MM, Dunivan G, Guaderrama NM, Richter HE. Digital therapeutic device for urinary incontinence. Obstet Gynecol Publish Ah. 2022;1\u201310. https:\/\/doi.org\/10.1097\/aog.0000000000004725","DOI":"10.1097\/aog.0000000000004725"},{"key":"5321_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/SPV.0000000000000993","volume":"27","author":"KL Barnes","year":"2021","unstructured":"Barnes KL, Cichowski S, Komesu YM, et al. Home Biofeedback Versus Physical Therapy for Stress Urinary Incontinence: A Randomized Trial. Female Pelvic Med Reconstr Surg. 2021;27:587\u201394. https:\/\/doi.org\/10.1097\/SPV.0000000000000993.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"5321_CR16","unstructured":"U.S. Food and Drug Administration Framework for FDA\u2019s Real-World Evidence Program. U.S. Food and Drug Administration Framework for FDA\u2019s Real-World Evidence Program. Available at: fda.gov\/media\/120060\/download. Accessed 27 April 2022."},{"key":"5321_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2165\/00019053-199915050-00001","volume":"15","author":"DA Revicki","year":"1999","unstructured":"Revicki DA, Frank L. Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies. Pharmacoeconomics. 1999;15:423\u201334. https:\/\/doi.org\/10.2165\/00019053-199915050-00001.","journal-title":"Pharmacoeconomics"},{"key":"5321_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","volume":"193","author":"MD Barber","year":"2005","unstructured":"Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obs Gynecol. 2005;193:103\u201313. https:\/\/doi.org\/10.1016\/j.ajog.2004.12.025.","journal-title":"Am J Obs Gynecol"},{"key":"5321_CR19","first-page":"5195","volume":"17","author":"SE Straus","year":"2010","unstructured":"Straus SE, Holroyd-Leduc J, Orr MS. Validation of electronic urinary incontinence questionnaires. Can J Urol. 2010;17:5195\u20139.","journal-title":"Can J Urol"},{"key":"5321_CR20","doi-asserted-by":"publisher","first-page":"580.e1","DOI":"10.1016\/j.ajog.2009.02.007","volume":"200","author":"MD Barber","year":"2009","unstructured":"Barber MD, Spino C, Janz NK, et al. The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol. 2009;200:580.e1-580.e7. https:\/\/doi.org\/10.1016\/j.ajog.2009.02.007.","journal-title":"Am J Obstet Gynecol"},{"key":"5321_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/M13-2410","volume":"161","author":"A Qaseem","year":"2014","unstructured":"Qaseem A, Dallas P, Forciea MA, et al. Nonsurgical management of urinary incontinence in women: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161:429\u201340. https:\/\/doi.org\/10.7326\/M13-2410.","journal-title":"Ann Intern Med"},{"key":"5321_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101842","volume":"49","author":"A Favre-Inhofer","year":"2020","unstructured":"Favre-Inhofer A, Dewaele P, Millet P, Deffieux X. Systematic review of guidelines for urinary incontinence in women. J Gynecol Obstet Hum Reprod. 2020;49: 101842. https:\/\/doi.org\/10.1016\/j.jogoh.2020.101842.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"5321_CR23","doi-asserted-by":"publisher","unstructured":"Porta Roda O, D\u00edaz L\u00f3pez MA, Vara Paniagua J, et al. Adherence to pelvic floor muscle training with or without vaginal spheres in women with urinary incontinence: a secondary analysis from a randomized trial. Int Urogynecol J. https:\/\/doi.org\/10.1007\/s00192-015-2941-0","DOI":"10.1007\/s00192-015-2941-0"},{"key":"5321_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/09593985.2018.1482583","volume":"36","author":"C Sacomori","year":"2020","unstructured":"Sacomori C, Berghmans B, de Bie R, et al. Predictors for adherence to a home-based pelvic floor muscle exercise program for treating female urinary incontinence in Brazil. Physiother Theory Pract. 2020;36:186\u201395. https:\/\/doi.org\/10.1080\/09593985.2018.1482583.","journal-title":"Physiother Theory Pract"},{"key":"5321_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040819","volume":"11","author":"P Rygh","year":"2021","unstructured":"Rygh P, Asklund I, Samuelsson E. Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study. BMJ Open. 2021;11: e040819. https:\/\/doi.org\/10.1136\/bmjopen-2020-040819.","journal-title":"BMJ Open"},{"key":"5321_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00192-021-04683-4","volume":"33","author":"A von Au","year":"2022","unstructured":"von Au A, Wallwiener S, Matthies LM, et al. The burden of incontinence in a real-world data environment-insights from a digital patient companion. Int Urogynecol J. 2022;33:977\u201384. https:\/\/doi.org\/10.1007\/s00192-021-04683-4.","journal-title":"Int Urogynecol J"}],"updated-by":[{"DOI":"10.1007\/s00192-023-05596-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000}}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05321-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-022-05321-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05321-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T12:01:45Z","timestamp":1687867305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-022-05321-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["5321"],"URL":"https:\/\/doi.org\/10.1007\/s00192-022-05321-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00192-023-05596-0","asserted-by":"object"}]},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"11 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00192-023-05596-0","URL":"https:\/\/doi.org\/10.1007\/s00192-023-05596-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was financed by Renovia Inc., the product manufacturer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclaimers"}},{"value":"LEK, JLM, and SJP are employees of Renovia Inc. The nature of their employment supports clinical research, scientific exchange, and education and aligns with the aims of this study. They have obtained research, ethics, and compliance training and are CITI certified. MMW has no conflicts of interest to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}